Factors associated with glycemic variability in Japanese patients with diabetes

Chihiro Tanaka, Yoshifumi Saisho, Kumiko Tanaka, Kinsei Kou, Masami Tanaka, Shu Meguro, Junichiro Irie, Rie Jo, Toshihide Kawai, Hiroshi Itoh

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The aim of this study was to clarify determinants of glycemic variability in Japanese patients with diabetes. We performed continuous glucose monitoring (CGM) for 2-4 days in 88 patients with diabetes admitted to our hospital for poor glycemic control (20 with type 1 and 68 with type 2 diabetes). Glycemic variability was assessed by standard deviation (SD) of glucose and mean amplitude of glycemic excursions (MAGE) calculated from CGM data, and its relations to clinical parameters were investigated. Beta-cell function was assessed by serum C-peptide immunoreactivity (CPR) to glucose ratio (CPR index). As a result, glycemic variability was significantly greater in patients with type 1 diabetes than in those with type 2 diabetes. In all patients, the glycated albumin to HbA1c ratio (GA/HbA1c) was positively correlated and the postprandial CPR index was negatively correlated with SD and MAGE (both p < 0.05). In patients with type 2 diabetes, age, diabetes duration, and GA/HbA1c were significantly positively correlated with SD and MAGE, while multivariate analysis suggested that age and diabetes duration are the major determinants of glycemic variability. In conclusion, while glycemic variability was greater in patients with type 1 diabetes than those with type 2 diabetes, age, diabetes duration, GA/HbA1c, and beta-cell function were associated with glycemic variability in Japanese patients with diabetes.

Original languageEnglish
Pages (from-to)36-42
Number of pages7
JournalDiabetology International
Volume5
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Type 2 Diabetes Mellitus
C-Peptide
Glucose
Type 1 Diabetes Mellitus
Multivariate Analysis
Serum
glycosylated serum albumin

Keywords

  • Age
  • Beta-cell function
  • Continuous glucose monitoring
  • Glycated albumin
  • Glycemic variability
  • Type 2 diabetes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Factors associated with glycemic variability in Japanese patients with diabetes. / Tanaka, Chihiro; Saisho, Yoshifumi; Tanaka, Kumiko; Kou, Kinsei; Tanaka, Masami; Meguro, Shu; Irie, Junichiro; Jo, Rie; Kawai, Toshihide; Itoh, Hiroshi.

In: Diabetology International, Vol. 5, No. 1, 2014, p. 36-42.

Research output: Contribution to journalArticle

Tanaka, Chihiro ; Saisho, Yoshifumi ; Tanaka, Kumiko ; Kou, Kinsei ; Tanaka, Masami ; Meguro, Shu ; Irie, Junichiro ; Jo, Rie ; Kawai, Toshihide ; Itoh, Hiroshi. / Factors associated with glycemic variability in Japanese patients with diabetes. In: Diabetology International. 2014 ; Vol. 5, No. 1. pp. 36-42.
@article{b01ac2e2d6c14d6d866ff868bfe028db,
title = "Factors associated with glycemic variability in Japanese patients with diabetes",
abstract = "The aim of this study was to clarify determinants of glycemic variability in Japanese patients with diabetes. We performed continuous glucose monitoring (CGM) for 2-4 days in 88 patients with diabetes admitted to our hospital for poor glycemic control (20 with type 1 and 68 with type 2 diabetes). Glycemic variability was assessed by standard deviation (SD) of glucose and mean amplitude of glycemic excursions (MAGE) calculated from CGM data, and its relations to clinical parameters were investigated. Beta-cell function was assessed by serum C-peptide immunoreactivity (CPR) to glucose ratio (CPR index). As a result, glycemic variability was significantly greater in patients with type 1 diabetes than in those with type 2 diabetes. In all patients, the glycated albumin to HbA1c ratio (GA/HbA1c) was positively correlated and the postprandial CPR index was negatively correlated with SD and MAGE (both p < 0.05). In patients with type 2 diabetes, age, diabetes duration, and GA/HbA1c were significantly positively correlated with SD and MAGE, while multivariate analysis suggested that age and diabetes duration are the major determinants of glycemic variability. In conclusion, while glycemic variability was greater in patients with type 1 diabetes than those with type 2 diabetes, age, diabetes duration, GA/HbA1c, and beta-cell function were associated with glycemic variability in Japanese patients with diabetes.",
keywords = "Age, Beta-cell function, Continuous glucose monitoring, Glycated albumin, Glycemic variability, Type 2 diabetes",
author = "Chihiro Tanaka and Yoshifumi Saisho and Kumiko Tanaka and Kinsei Kou and Masami Tanaka and Shu Meguro and Junichiro Irie and Rie Jo and Toshihide Kawai and Hiroshi Itoh",
year = "2014",
doi = "10.1007/s13340-013-0129-8",
language = "English",
volume = "5",
pages = "36--42",
journal = "Diabetology International",
issn = "2190-1678",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Factors associated with glycemic variability in Japanese patients with diabetes

AU - Tanaka, Chihiro

AU - Saisho, Yoshifumi

AU - Tanaka, Kumiko

AU - Kou, Kinsei

AU - Tanaka, Masami

AU - Meguro, Shu

AU - Irie, Junichiro

AU - Jo, Rie

AU - Kawai, Toshihide

AU - Itoh, Hiroshi

PY - 2014

Y1 - 2014

N2 - The aim of this study was to clarify determinants of glycemic variability in Japanese patients with diabetes. We performed continuous glucose monitoring (CGM) for 2-4 days in 88 patients with diabetes admitted to our hospital for poor glycemic control (20 with type 1 and 68 with type 2 diabetes). Glycemic variability was assessed by standard deviation (SD) of glucose and mean amplitude of glycemic excursions (MAGE) calculated from CGM data, and its relations to clinical parameters were investigated. Beta-cell function was assessed by serum C-peptide immunoreactivity (CPR) to glucose ratio (CPR index). As a result, glycemic variability was significantly greater in patients with type 1 diabetes than in those with type 2 diabetes. In all patients, the glycated albumin to HbA1c ratio (GA/HbA1c) was positively correlated and the postprandial CPR index was negatively correlated with SD and MAGE (both p < 0.05). In patients with type 2 diabetes, age, diabetes duration, and GA/HbA1c were significantly positively correlated with SD and MAGE, while multivariate analysis suggested that age and diabetes duration are the major determinants of glycemic variability. In conclusion, while glycemic variability was greater in patients with type 1 diabetes than those with type 2 diabetes, age, diabetes duration, GA/HbA1c, and beta-cell function were associated with glycemic variability in Japanese patients with diabetes.

AB - The aim of this study was to clarify determinants of glycemic variability in Japanese patients with diabetes. We performed continuous glucose monitoring (CGM) for 2-4 days in 88 patients with diabetes admitted to our hospital for poor glycemic control (20 with type 1 and 68 with type 2 diabetes). Glycemic variability was assessed by standard deviation (SD) of glucose and mean amplitude of glycemic excursions (MAGE) calculated from CGM data, and its relations to clinical parameters were investigated. Beta-cell function was assessed by serum C-peptide immunoreactivity (CPR) to glucose ratio (CPR index). As a result, glycemic variability was significantly greater in patients with type 1 diabetes than in those with type 2 diabetes. In all patients, the glycated albumin to HbA1c ratio (GA/HbA1c) was positively correlated and the postprandial CPR index was negatively correlated with SD and MAGE (both p < 0.05). In patients with type 2 diabetes, age, diabetes duration, and GA/HbA1c were significantly positively correlated with SD and MAGE, while multivariate analysis suggested that age and diabetes duration are the major determinants of glycemic variability. In conclusion, while glycemic variability was greater in patients with type 1 diabetes than those with type 2 diabetes, age, diabetes duration, GA/HbA1c, and beta-cell function were associated with glycemic variability in Japanese patients with diabetes.

KW - Age

KW - Beta-cell function

KW - Continuous glucose monitoring

KW - Glycated albumin

KW - Glycemic variability

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84896500670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896500670&partnerID=8YFLogxK

U2 - 10.1007/s13340-013-0129-8

DO - 10.1007/s13340-013-0129-8

M3 - Article

VL - 5

SP - 36

EP - 42

JO - Diabetology International

JF - Diabetology International

SN - 2190-1678

IS - 1

ER -